#Rockville,_MD
AHRQ's Super Intelligence Competition Aims to Revolutionize Healthcare Evidence Evaluation#None#Healthcare_Innovation#Rockville,_MD#AHRQ#Super_Intelligence
AHRQ's Super Intelligence Competition Aims to Revolutionize Healthcare Evidence Evaluation
AHRQ's Super Intelligence Prize competition introduces innovative approaches to transform healthcare data analysis, improving patient outcomes significantly.
third-news.com
October 7, 2026 at 4:17 PM
SciNeuro Pharmaceuticals Secures $5M to Advance Innovative Parkinson's Treatment Through MJFF Grant#United_States#Michael_J._Fox#Rockville,_MD#LRRK2#SciNeuro
SciNeuro Pharmaceuticals Secures $5M to Advance Innovative Parkinson's Treatment Through MJFF Grant
SciNeuro Pharmaceuticals has been awarded a $5M grant from The Michael J. Fox Foundation to enhance the development of its innovative LRRK2-targeting therapeutic, SNP614, for Parkinson's disease.
third-news.com
November 20, 2025 at 12:38 PM
Cardinality.ai Launches CardyCares: Revolutionizing Healthcare Services with AI#USA#Healthcare_Solutions#Cardinality.ai#Rockville,_MD#CardyCares
Cardinality.ai Launches CardyCares: Revolutionizing Healthcare Services with AI
Cardinality.ai introduces CardyCares, a healthcare solutions suite aimed at modernizing Medicaid Enterprise Systems through innovative AI tools.
third-news.com
September 12, 2025 at 3:15 PM
Westat Introduces WesLytics: Elevating Data Management through AI Integration#USA#Westat#Databricks#Rockville,_MD#WesLytics
Westat Introduces WesLytics: Elevating Data Management through AI Integration
Discover how Westat's new WesLytics platform combines expert data management with Databricks AI to deliver powerful insights.
third-news.com
August 12, 2025 at 7:39 PM
ANSI Rebrands Annual Conference as ANSI Innovation Summit to Promote Standards-Driven Innovation#United_States#Innovation#Standards#ANSI#Rockville,_MD
ANSI Rebrands Annual Conference as ANSI Innovation Summit to Promote Standards-Driven Innovation
The American National Standards Institute (ANSI) rebrands its annual conference to the ANSI Innovation Summit, emphasizing the role of standards in innovation and global competitiveness.
third-news.com
July 17, 2025 at 4:13 PM
REGENXBIO Unveils Promising Phase I/II Trial Results for Gene Therapy RGX-202 Aiming at Duchenne Muscular Dystrophy#United_States#Duchenne#REGENXBIO#RGX-202#Rockville,_MD
REGENXBIO Unveils Promising Phase I/II Trial Results for Gene Therapy RGX-202 Aiming at Duchenne Muscular Dystrophy
Recent findings from REGENXBIO's Phase I/II trial demonstrate RGX-202's positive impact on Duchenne muscular dystrophy, indicating significant functional benefits.
third-news.com
June 5, 2025 at 11:22 AM